Saturday, July 11, 2026

Drug profile · INN

immunocheckpoint

immunocheckpoint is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — immunocheckpoint
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

immunocheckpoint is an FDA-listed pharmaceutical active ingredient.

Key facts

INN immunocheckpoint

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. CABOZANTINIB Phase 2 · Telethon Foundation · Patients with metastatic clear cell renal cell carcinoma pre
  2. POINT Phase 2 · Telethon Foundation · Adult patients affected by recurrent/metastatic, platinum re
  3. Point of Care testing Approved · Universal Integrated · Acute Coronary Syndrome

Frequently asked questions

What is immunocheckpoint?

immunocheckpoint is an FDA-listed pharmaceutical active ingredient.